Arthralgies, effets secondaires des inhibiteurs de l’aromatase: fréquence, signification et conséquences-Reference-Cited by-同舟云学术

Arthralgies, effets secondaires des inhibiteurs de l’aromatase: fréquence, signification et conséquences

Published:2012-06 Issue:6-7 Volume:14 Page:365-373
ISSN:1292-3818
Container-title:Oncologie
language:fr
Short-container-title:Oncologie

Author:

Lesur A.,Barlier C.

Publisher

Computers, Materials and Continua (Tech Science Press)

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10269-012-2180-7.pdf

Reference90 articles.

1. Amir E, Seruga B, Niraula S (2011) Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst 103(17): 1299–1309

2. Azria D, Lamy PJ, Belkacemi Y, et al. (2006) Letrozole-induced arthralgia is not consistent with an autoimmune disease resembling Sjögren’s syndrome: Preliminary results of a multicentric prospective trial. Breast Cancer Res Treat 100: S25(Suppl 1; abstr 106)

3. Banning M (2012) Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review Eur J Cancer Care 21(1): 10–19

4. Barron TI, Connolly R, Bennett K, et al. (2007) Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 109: 832–839

5. Baum M, Budzar AU, Cuzick J, et al. (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359: 2131–2139

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Référentiels inter régionaux en Soins Oncologiques de Support;Oncologie;2015-10

2. Acquis et limites de l’hormonothérapie adjuvante;Acquis et limites en sénologie / Assets and limits in breast diseases;2013

3. 2002–2012 : une décennie maudite pour les estrogènes…;Gynécologie Obstétrique & Fertilité;2012-11